Skip to main content
Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.800
-0.050 (-1.03%)
At close: Dec 5, 2025

Veradigm Revenue

In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.

Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.39
Revenue / Employee
240.01K
Employees
2,450
Market Cap
815.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022588.02M10.59M1.83%
Dec 31, 2021577.43M21.31M3.83%
Dec 31, 2020556.12M-1.08B-65.94%
Dec 31, 20191.63B14.77M0.91%
Dec 31, 20181.62B120.13M8.02%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Nuo Therapeutics 2.61M
Revenue Rankings

Veradigm News

More News